We recently demonstrated that the inhibitory receptor T cell immunoreceptor with Ig and ITIM domains (TIGIT) assembles in nanoscale clusters at the T cell surface upon ligation with its ligand CD155. Crucially, these TIGIT-rich nanoclusters co-localise with T cell receptor (TCR) nanoclusters [1], concurrent with reduced effector functions, such as production of the cytokine IL-2 upon superantigen stimulation. TIGIT with mutations that prevented transduction of inhibitory signals via its ITT-like and ITIM domains, still clustered upon ligation with CD155 and localised to TCR clusters, but could not inhibit functional outcomes. Thus, inhibitory TIGIT signalling localised to the TCR leads to less cellular activation. The question arises: is the nanoscale proximity of inhibitory and stimulatory receptors, like TIGIT and the TCR, essential for inhibitory function?
There are two main ways in which proximity of an inhibitory receptor to a stimulatory receptor could be important for functional inhibition: (i) Inhibitory receptors act to disrupt local stimulatory receptor signalling, and/or (ii) Inhibitory receptors require signals from stimulatory receptors to be stimulated themselves. Here, we provide examples with the inhibitory receptors PD-1, CTLA-4 and LAG3 that support each of these views (summarised in Fig. 1).
Evidence that inhibitory receptors are recruited to stimulatory receptors
PD-1 clusters at the immune synapse upon ligation with PD-L1 and PD-L2 [2, 3]. Initially, it was observed that PD-1 clusters co-localised with TCR clusters in murine T cells early in immune synapse formation [2]. Later, this model was refined as it was demonstrated that PD-1 better co-localises with the co-stimulatory molecule CD28 throughout the maturation of the immune synapse [3]. CTLA-4 constantly traffics from subcellular vesicles to the membrane but is predominantly localised in subcellular compartments. Both TCR stimulation and interaction with B7 ligands in trans, causes CTLA-4 accumulation and clustering at the immune synapse [4, 5]. CTLA-4 clustered proximally to TCR early in synapse formation, and associated with the peripheral synaptic region when the TCR concentrates to a central cluster at later timepoints. Likewise, LAG3 also clusters with the TCR at the immune synapse, in a ligand-independent manner [6]. Thus, several different types of inhibitory receptors are specifically recruited to activating receptors at immune synapses.
Evidence that inhibitory receptors act locally to disrupt stimulatory signalling
PD-1 ligation with PD-L1 or PD-L2 leads to phosphorylation of PD-1 [2], which can then recruit the phosphatase SHP-2, leading to dephosphorylation of proximal CD28 molecules and inactivation of CD28 signalling [3]. CTLA-4 at the synapse can also reduce proximal CD28 signalling [5], likely mediated by both competing for B7 ligand binding in trans and internalisation of trogocytosed B7 ligands through either trans or cis-endocytosis, which could be enhanced by co-proximity [7, 8]. Proximal disruption by inhibitory receptors does not necessarily require phosphorylation-mediated signalling. Accumulation of LAG3 at TCR complexes increased its proximity to the co-receptors CD4 and CD8, which led to localised acidification through its glutamic acid-proline dipeptide repeat (EP motif), in turn disrupting Lck-CD4 or Lck-CD8 interactions and subsequent co-stimulation [6].
Evidence that inhibitory receptors require local stimulation to function
Chimeric versions of PD-1 that contained different numbers of Ig domains in its extracellular tail had differing inhibitory potential, conistent with the kinetic-segretaion model of positioning proteins at the immune syanpse according to their size [2]. PD-1 with large extracellular domains were excluded from TCR clusters and could not prevent downstream TCR signalling and IL-2 secretion. Additionally, PD-1 phosphorylation only occurred when PD-1 was ligated and colocalised with the TCR, which correlated with SHP-2 recruitment. This is evidence that PD-1 proximity to the TCR is critical to initiate functional inhibitory signalling. This is not limited to T cells, as inhibition by Killer Ig-like receptors required proximity to the activating receptor NKG2D at the surface of human NK cells, which could also be perturbed by altered protein size [9].
Other evidence is that TCR stimulation leads to an accumulation of CTLA-4 at the immune synapse in a manner dependent on the TCR signalling strength [4]. The Src-family kinase, Lck, can phosphorylate cytoplasmic CTLA-4 tyrosine residues which promotes its localisation from subcellular vesicles to the membrane [10]. Stimulation of the TCR generates hubs of Lck activity at the immune synapse that could lead to localised surface enrichment of CTLA-4 where it can bind to B7 ligands to provide negative feedback.
Concluding remarks
Providing inhibitory signals to cells that do not require inhibition would feasibly be wasteful of cellular activity and resources. This could provide an evolutionary rationale for inhibitory signalling to only act where and when it is necessary. Often, textbook diagrams depict receptor transduction occurring solely upon ligation, but this is too simplistic as inhibitory receptor signalling is context specific. Initiating inhibitory processes likely requires signals from local stimulatory receptor signalling hubs, as is the case for PD-1, CTLA-4 and potentially for TIGIT. In some cases, inhibitory receptors may not require signalling to function as their proximity to stimulatory receptors by itself can be inhibitory, as with LAG3. Limiting the ability of inhibitory receptors to function at precise nanoscale locations of stimulation permits a spatiotemporal regulation governed by stimulatory signals, providing highly efficient regulatory mechanisms.
References
Worboys JD, Vowell KN, Hare RK, Ambrose AR, Bertuzzi M, Conner MA, et al. TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation. Nat Commun. 2023;14:5016. https://doi.org/10.1038/s41467-023-40755-3.
Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012;209:1201–17. https://doi.org/10.1084/jem.20112741.
Hui E, Cheung J, Zhu J, Su X, Taylor MJ, Wallweber HA, et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science. 2017;355:1428–33. https://doi.org/10.1126/science.aaf1292.
Egen JG, Allison JP. Cytotoxic T. lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity. 2002;16:23–35. https://doi.org/10.1016/s1074-7613(01)00259-x.
Yokosuka T, Kobayashi W, Takamatsu M, Sakata-Sogawa K, Zeng H, Hashimoto-Tane A, et al. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity. 2010;33:326–39. https://doi.org/10.1016/j.immuni.2010.09.006.
Guy C, Mitrea DM, Chou PC, Temirov J, Vignali KM, Liu X, et al. LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation. Nat Immunol. 2022;23:757–67. https://doi.org/10.1038/s41590-022-01176-4.
Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332:600–3. https://doi.org/10.1126/science.1202947.
Xu X, Dennett P, Zhang J, Sherrard A, Zhao Y, Masubuchi T, et al. CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis. J Exp Med. 2023;220:e20221391. https://doi.org/10.1084/jem.20221391.
Köhler K, Xiong S, Brzostek J, Mehrabi M, Eissmann P, Harrison A, et al. Matched sizes of activating and inhibitory receptor/ligand pairs are required for optimal signal integration by human natural killer cells. PloS one. 2010;5:e15374. https://doi.org/10.1371/journal.pone.0015374.
Bradshaw JD, Lu P, Leytze G, Rodgers J, Schieven GL, Bennett KL, et al. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry. 1997;36:15975–82. https://doi.org/10.1021/bi971762i.
Acknowledgements
The authors thank all members of the Davis laboratory for helpful discussions. This work was supported through funding from GSK, the Medical Research Council (MR/W031698/1 to D.M.D), the Wellcome Trust (Investigator Award; 110091/Z/15/Z to D.M.D.) and the Manchester Collaborative Centre for Inflammation Research (funded by a precompetitive open-innovation award from GSK, AstraZeneca, and The University of Manchester, United Kingdom).
Author information
Authors and Affiliations
Contributions
JDW and DMD both conceptualised and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
DMD is a consultant and advisor to GSK. JDW declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Worboys, J.D., Davis, D.M. Do inhibitory receptors need to be proximal to stimulatory receptors to function?. Genes Immun (2024). https://doi.org/10.1038/s41435-023-00251-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41435-023-00251-6